Half-year report · HY
286A.TEDINET S100YWR5
Period2026-01-01 → 2026-06-30
Filed2026-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.7bn | 2026-01-01 → 2026-06-30 | Cons. | Net sales |
| Revenue | ¥24.7bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.5bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Operating income | ¥395m | 2026-01-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | ¥361m | 2026-01-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥981m | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥256m | 2026-01-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.2bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥489m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.8bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥824m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥560m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | ¥887m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥67.5bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥65.1bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥61.2bn | at 2025-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥45.2bn | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥43.3bn | at 2025-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥22.3bn | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥21.8bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥19.7bn | at 2025-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥11.0bn | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.1bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.9bn | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.1bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.2bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.1bn | at 2024-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥551m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.9bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥92m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.3bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.4bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.2bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.8bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥856m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥13.67 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥78.07 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.2 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥13.57 | 2026-01-01 → 2026-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥76.75 | 2025-01-01 → 2025-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.75 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 31.2% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.5% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.3% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 50
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2026-01-01 → 2026-06-30 | ¥376m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2026-01-01 → 2026-06-30 | ¥376m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2026-01-01 → 2026-06-30 | ¥118m |
| Reconciling Itemsreconciling | revenue | 2026-01-01 → 2026-06-30 | −¥16m |
| Reconciling Itemsreconciling | revenue intersegment | 2026-01-01 → 2026-06-30 | −¥16m |
| Reconciling Itemsreconciling | segment profit | 2026-01-01 → 2026-06-30 | −¥731m |
| Comprehensive Medical Management Support Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥5.1bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥5.0bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥15m |
| Comprehensive Medical Management Support Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥457m |
| Elderly Care Related Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥4.4bn |
| Elderly Care Related Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥4.4bn |
| Elderly Care Related Businessreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥740,000 |
| Elderly Care Related Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥312m |
| Specially Controlled Medical Device Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥3.8bn |
| Specially Controlled Medical Device Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥3.8bn |
| Specially Controlled Medical Device Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥240m |
| —segment total | revenue | 2026-01-01 → 2026-06-30 | ¥13.3bn |
| —segment total | revenue external | 2026-01-01 → 2026-06-30 | ¥13.3bn |
| —segment total | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥16m |
| —segment total | segment profit | 2026-01-01 → 2026-06-30 | ¥1.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2026-01-01 → 2026-06-30 | ¥13.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2026-01-01 → 2026-06-30 | ¥13.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥16m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2026-01-01 → 2026-06-30 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-01-01 → 2025-06-30 | ¥219m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-01-01 → 2025-06-30 | ¥219m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-01-01 → 2025-06-30 | ¥41m |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥640,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥640,000 |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥670m |
| Comprehensive Medical Management Support Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.1bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.1bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥395,000 |
| Comprehensive Medical Management Support Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥1.3bn |
| Elderly Care Related Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.7bn |
| Elderly Care Related Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.7bn |
| Elderly Care Related Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥245,000 |
| Elderly Care Related Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥187m |
| Specially Controlled Medical Device Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.6bn |
| Specially Controlled Medical Device Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.6bn |
| Specially Controlled Medical Device Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥276m |
| —segment total | revenue | 2025-01-01 → 2025-06-30 | ¥10.3bn |
| —segment total | revenue external | 2025-01-01 → 2025-06-30 | ¥10.3bn |
| —segment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥640,000 |
| —segment total | segment profit | 2025-01-01 → 2025-06-30 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-01-01 → 2025-06-30 | ¥10.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-01-01 → 2025-06-30 | ¥10.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥640,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-01-01 → 2025-06-30 | ¥1.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 552
| Item | Context | Value | Unit |
|---|---|---|---|
| Real estate for sale | Prior1YearInstant | 1612882000 | JPY |
| Real estate for sale | InterimInstant | 1895575000 | JPY |
| Other ca | Prior1YearInstant | 9560760000 | JPY |
| Other ca | InterimInstant | 10894942000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -78975000 | JPY |
| Allowance for doubtful accounts ca | InterimInstant | -78221000 | JPY |
| Current assets | Prior1YearInstant | 27210103000 | JPY |
| Current assets | InterimInstant | 29591730000 | JPY |
| Buildings and structures net | Prior1YearInstant | 10544516000 | JPY |
| Buildings and structures net | InterimInstant | 10300889000 | JPY |
| Land | Prior1YearInstant | 15484210000 | JPY |
| Land | InterimInstant | 15463878000 | JPY |
| Lease assets net ppe | Prior1YearInstant | 5521679000 | JPY |
| Lease assets net ppe | InterimInstant | 5398494000 | JPY |
| Other net ppe | Prior1YearInstant | 181039000 | JPY |
| Other net ppe | InterimInstant | 295555000 | JPY |
| Property plant and equipment | Prior1YearInstant | 31731445000 | JPY |
| Property plant and equipment | InterimInstant | 31458818000 | JPY |
| Goodwill | Prior1YearInstant | 2346596000 | JPY |
| Goodwill | InterimInstant | 2296485000 | JPY |
| Other ia | Prior1YearInstant | 563305000 | JPY |
| Other ia | InterimInstant | 550762000 | JPY |
| Intangible assets | Prior1YearInstant | 2909901000 | JPY |
| Intangible assets | InterimInstant | 2847247000 | JPY |
| Other ioa | Prior1YearInstant | 3281736000 | JPY |
| Other ioa | InterimInstant | 3576178000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -7399000 | JPY |
| Allowance for doubtful accounts ioa by group | InterimInstant | -7888000 | JPY |
| Investments and other assets | Prior1YearInstant | 3274337000 | JPY |
| Investments and other assets | InterimInstant | 3568289000 | JPY |
| Noncurrent assets | Prior1YearInstant | 37915684000 | JPY |
| Noncurrent assets | InterimInstant | 37874355000 | JPY |
| Assets | Prior1YearInstant | 65125788000 | JPY |
| Assets | InterimInstant | 67466086000 | JPY |
| Accounts payable trade | Prior1YearInstant | 2093378000 | JPY |
| Accounts payable trade | InterimInstant | 2356786000 | JPY |
| Short term loans payable | Prior1YearInstant | 4211785000 | JPY |
| Short term loans payable | InterimInstant | 6961698000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant | 1822546000 | JPY |
| Current portion of long term loans payable | InterimInstant | 1692730000 | JPY |
| Income taxes payable | Prior1YearInstant | 240125000 | JPY |
| Income taxes payable | InterimInstant | 221274000 | JPY |
| Provision for bonuses | Prior1YearInstant | 576266000 | JPY |
| Provision for bonuses | InterimInstant | 457543000 | JPY |
| Provision for shareholder benefit program cl | Prior1YearInstant | 5946000 | JPY |
| Provision for shareholder benefit program cl | InterimInstant | － | JPY |
| Other cl | Prior1YearInstant | 3609267000 | JPY |
| Other cl | InterimInstant | 3200403000 | JPY |
| Current liabilities | Prior1YearInstant | 12559315000 | JPY |
| Current liabilities | InterimInstant | 14890436000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |